About this trial
This study is an observational multi-country cohort study that aims to build algorithms that can identify children between 5 and 16 years of age admitted for proven or suspected sepsis who are at risk of mortality after they are discharged in East Africa.
In low- and middle-income countries, about 5% of children discharged after hospitalization for sepsis will die in the weeks after returning home. Doctors and parents are often unaware of this period of vulnerability and are poorly equipped to identify or handle this critical situation. This project builds on past work that developed and evaluated models and the Smart Discharges program to predict, during hospitalization, an individual child's risk of recurrent illness and mortality, as well as to provide additional post-discharge support to at-risk children.
Participants will be enrolled from facilities once they are admitted, collecting clinical and social variables. They will then be followed until 6 months post-discharge to understand what happens to them after they return home. This data will be evaluated to identify which variables collected at facilities can be predictive of mortality and recurrent illness after discharge.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 0 and 16 years admitted to pediatric ward of hospital for proven or suspected infection
Provide informed consent
Ability to provide contact information (phone number or address) for phone or in-person follow-up
Disqualifiers
Child lives outside of the catchment area of a study site
Admitted for elective procedures, trauma, or short-term observation
Language barriers
Trial population
The study population is children admitted to hospital facilities with suspected or proven sepsis between 5-16 years of age in the catchment area of the 8 study sites: Mbarara Regional Referral Hospital (Uganda), Jinja Regional Referral Hospital (Uganda), Uganda Martyrs Ibanda Hospital (Uganda), Holy Innocents Children's Hospital (Uganda), Sekou-Toure Regional Referral Hospital (Tanzania), Bugando Medical Centre (Tanzania), Masaka Hospital (Rwanda), University Teaching Hospital of Kigali (Rwanda), Ruhengeri Referral Hospital (Rwanda).
Trial design
Cohort
Prospective
Treatments tested in this trial
No Intervention: Observational Cohort
Other interventionThis is a non-interventional study
Treatment groups
Trial outcomes
Primary outcomes
Number of children who die post-discharge
Secondary outcomes
Number of children readmitted to a health facility post-discharge
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of British Columbia
Lead sponsor
University of California, San Francisco
Collaborator
World Alliance for Lung and Intensive Care Medicine in Uganda
Collaborator
Catholic University of Health and Allied Sciences
Collaborator
Centre Hospitalier Universitaire de Kigali
Collaborator